Results: Twenty-six patients with ala suspension sutures inserted were identified. Five patients who had concurrent procedures carried out on septum and turbinates were excluded. Twenty-one patients were included in our study. Ninety percent of patients were satisfied with the surgery, supported by significant improvement in the VAS (0 -10) for nasal congestion and PIFR scores. The average VAS score improvement was 4.6 points, and PIFR increased by 23.3L/min. Of the 21 patients, 4 required revision procedures to achieve satisfactory outcome. Two out of these 4 developed neuralgia, which was controlled with Amitriptyline.
Conclusion:
The result of our study shows a significant improvement in patient symptoms following insertion of ala suspension suture for nasal valve collapse causing nasal obstruction. This is a short and well tolerated procedure with minimal side effects.
Rhinology/Allergy The Changes of Clinical Characteristics of Pre-and Post immunotherapy in Allergic Rhinitis Patients Sensitized to Dermatophagoides farinae (Df) Su Young Jung, MD (presenter); Jung Seang Cho
Objective: By analyzing the difference of clinical manifestations, such as MAST results, total IgE, and Eosinophil count, before and after IT in AR patients who have been sensitized to the Df allergen, this research tried to find out about the character of the treatment response.
Method:
The study included 192 patients, excluding one patient who stopped therapy during the process. After dividing the group by the duration of therapy and the degree of sensitization to the Df, the MAST, total IgE, and eosinophil count of each group were compared before and at least 6 months after therapy.
Results: After dividing the subjects into different groups according to the duration of IT into the 6 to 12-months group (n = 136) and the more than 12-months group (n = 56), the latter group showed a significant reduction in the Df specific antibody IgE, Dermatophagoides pteronyssinus (Dp) specific antibody IgE, and eosinophil count.
Conclusion:
In conclusion, immunotherapy has greater treatment response in patients with a more severe degree of sensitization to the Df allergen and the duration of treatment for more than 1 year.
Rhinology/Allergy The Effect of Slow-Release bFGF with Gelatin on Anosmia Mice
Jumpei Nota (presenter); Kiyofumi Gyo, MD; Naohito Hato, MD Objective: Basic fibroblast growth factor (bFGF) may regenerate the olfactory system. However, it does not work well because of short acting time. We developed a new drug delivery system by embedding bFGF in a gelatin hydrogel that degrades slowly. This study is designed to identify the effects of bFGF-hydrogel in anosmia mice.
Method: An anosmia mouse model was induced by i.p. injection of 3-methylindole. The animals were divided into four groups by the following procedures: group A, no further treatment; B, single intranasal administration of bFGF; C, single intranasal administration of PBS-hydrogel; D, single intranasal administration of bFGF-hydrogel. A month later, we evaluated by behavioral observations and histological findings.
Results:
The results for groups A, B, and C were similar in all investigations. In contrast, group D revealed better results; behavior observation showed improvement of olfactory loss and, in histological study, the thickness of olfactory epithelium and the number of Olfactory Marker Protein (OMP)-immunoreactive cells increased after a month. These results indicated the efficacy of single intranasal administration of embedding bFGF in hydrogel for impaired olfactory function.
Conclusion:
This preliminary study revealed the efficacy of a bFGF-impregnated biodegradable hydrogel as a drug-delivery medium in the olfactory mucosa. Single intranasal administration of embedding bFGF in hydrogel facilitates faster healing from olfactory dysfunction. Further studies are necessary to fully evaluate the usefulness of this procedure.
